Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Visualizing and interpreting cancer genomics data via the Xena platform
Goldman, M. J., Craft, B., Hastie, M., Repečka, K., McDade, F., Kamath, A., Banerjee, A., Luo, Y., Rogers, D., Brooks, A. N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0546-8 · Cited by 4,481
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930
Reimand, J., Isserlin, R., Voisin, V., Kucera, M., Tannus-Lopes, C., Rostamianfar, A., Wadi, L., Meyer, M., Wong, J., Xu, C., et al. (2019) · Nature Protocols · doi:10.1038/s41596-018-0103-9 · Cited by 1,970
AACR Project GENIE: Powering Precision Medicine through an International Consortium
The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0151 · Cited by 1,964
“Broad-based sharing of genomic and clinical data is therefore critical to realize the full potential of precision oncology (1), particularly as the scientific community evaluates the overall impact of genomic profiling on patient outcome and on clinical trial enrollment (2–5), and as the clinical community better leve…”
BackgroundLandscape of Microsatellite Instability Across 39 Cancer Types
Bonneville, R., Krook, M. A., Kautto, E. A., Miya, J., Wing, M. R., Chen, H.-Z., Reeser, J. W., Yu, L., & Roychowdhury, S. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00073 · Cited by 1,476
Cloughesy, T. F., Mochizuki, A. Y., Orpilla, J. R., Hugo, W., Lee, A. H., Davidson, T. B., Wang, A. C., Ellingson, B. M., Rytlewski, J. A., Sanders, C. M., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0337-7 · Cited by 1,382
Bartha, Á., & Győrffy, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052622 · Cited by 1,060
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
The National Sleep Research Resource: towards a sleep data commons
Zhang, G.-Q., Cui, L., Mueller, R., Tao, S., Kim, M., Rueschman, M., Mariani, S., Mobley, D., & Redline, S. (2018) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocy064 · Cited by 917
“We believe that the Data Commons vision is best achieved by in-stantiating it through disease-or domain-specific efforts, such as the NCI Genomic Data Commons (GDC 47,48 ).”
BackgroundDiffusion models in medical imaging: A comprehensive survey
Kazerouni, A., Aghdam, E. K., Heidari, M., Azad, R., Fayyaz, M., Hacihaliloglu, I., & Merhof, D. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102846 · Cited by 765
“Experiments on the Cancer Genome Atlas (TCGA) dataset [126] exhibit the superiority of the proposed method compared to GAN-based approaches [127].”
MethodPan-cancer computational histopathology reveals mutations, tumor composition and prognosis
Fu, Y., Jung, A. W., Torne, R. V., Gonzalez, S., Vöhringer, H., Shmatko, A., Yates, L. R., Jimenez-Linan, M., Moore, L., & Gerstung, M. (2020) · Nature Cancer · doi:10.1038/s43018-020-0085-8 · Cited by 653
Advancing targeted protein degradation for cancer therapy
Dale, B., Cheng, M., Park, K.-S., Kaniskan, H. Ü., Xiong, Y., & Jin, J. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00365-x · Cited by 632
EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data
Racle, J., & Gfeller, D. (2020) · Methods in Molecular Biology · doi:10.1007/978-1-0716-0327-7_17 · Cited by 554
Implementing Genome-Driven Oncology
Hyman, D. M., Taylor, B. S., & Baselga, J. (2017) · Cell · doi:10.1016/j.cell.2016.12.015 · Cited by 503
Signatures of copy number alterations in human cancer
Steele, C. D., Abbasi, A., Islam, S. M. A., Bowes, A. L., Khandekar, A., Haase, K., Hames-Fathi, S., Ajayi, D., Verfaillie, A., Dhami, P., et al. (2022) · Nature · doi:10.1038/s41586-022-04738-6 · Cited by 501
Zhou, N., Yuan, X., Du, Q., Zhang, Z., Shi, X., Bao, J., Ning, Y., & Peng, L. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac935 · Cited by 498
Proteogenomic Characterization of Endometrial Carcinoma
Dou, Y., Kawaler, E. A., Cui Zhou, D., Gritsenko, M. A., Huang, C., Blumenberg, L., Karpova, A., Petyuk, V. A., Savage, S. R., Satpathy, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.026 · Cited by 485
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
“For example, the Genomic Data Commons program of the National Cancer Institute aims to provide a data repository that enables data sharing across cancer genomic studies in support of precision medicine (148).”
BackgroundThe UCSC Xena platform for public and private cancer genomics data visualization and interpretation
Goldman, M., Craft, B., Hastie, M., Repečka, K., Kamath, A., McDade, F., Rogers, D., Brooks, A. N., Zhu, J., & Haussler, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/326470 · Cited by 448
From hype to reality: data science enabling personalized medicine
Fröhlich, H., Balling, R., Beerenwinkel, N., Kohlbacher, O., Kumar, S., Lengauer, T., Maathuis, M. H., Moreau, Y., Murphy, S. A., Przytycka, T. M., et al. (2018) · BMC Medicine · doi:10.1186/s12916-018-1122-7 · Cited by 414
Accelerating Discovery of Functional Mutant Alleles in Cancer
Chang, M. T., Bhattarai, T. S., Schram, A. M., Bielski, C. M., Donoghue, M. T. A., Jonsson, P., Chakravarty, D., Phillips, S., Kandoth, C., Penson, A., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0321 · Cited by 409
“Pooling prospective genomic data from many sources may quickly achieve the scale needed to saturate the discovery of hotspots in most of the genes targetable with current drugs (27), expanding the reach of precision oncology.”
Multimodal data fusion for cancer biomarker discovery with deep learning
Steyaert, S., Pizurica, M., Nagaraj, D., Khandelwal, P., Hernandez-Boussard, T., Gentles, A. J., & Gevaert, O. (2023) · Nature Machine Intelligence · doi:10.1038/s42256-023-00633-5 · Cited by 402
“Large consortia such as The Cancer Genome Atlas (TCGA) and Genomic Data Commons have gathered and standardized large datasets, accumulating petabytes of genomic, expression and proteomics data 37,49,50 .”
BackgroundDeep Learning Models for Histopathological Classification of Gastric and Colonic Epithelial Tumours
Iizuka, O., Kanavati, F., Kato, K., Rambeau, M., Arihiro, K., & Tsuneki, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-58467-9 · Cited by 395
Targeting FAK in anticancer combination therapies
Dawson, J. C., Serrels, A., Stupack, D. G., Schlaepfer, D. D., & Frame, M. C. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00340-6 · Cited by 384
Müller-Dott, S., Tsirvouli, E., Vazquez, M., Ramirez Flores, R. O., Badia-i-Mompel, P., Fallegger, R., Türei, D., Lægreid, A., & Saez-Rodriguez, J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad841 · Cited by 380
Estimation of the Percentage of US Patients With Cancer Who Benefit From Genome-Driven Oncology
Marquart, J., Chen, E. Y., & Prasad, V. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1660 · Cited by 377
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis
Muhar, M., Ebert, A., Neumann, T., Umkehrer, C., Jude, J., Wieshofer, C., Rescheneder, P., Lipp, J. J., Herzog, V. A., Reichholf, B., et al. (2018) · Science · doi:10.1126/science.aao2793 · Cited by 372
Targeting a neoantigen derived from a common TP53 mutation
Hsiue, E. H.-C., Wright, K. M., Douglass, J., Hwang, M. S., Mog, B. J., Pearlman, A. H., Paul, S., DiNapoli, S. R., Konig, M. F., Wang, Q., et al. (2021) · Science · doi:10.1126/science.abc8697 · Cited by 367
“R175H, in which arginine at position 175 is replaced with histidine, is the most common mutation observed in TP53 as well as the most frequent mutation in any tumor suppressor gene (9).”
BackgroundCurrent progress and open challenges for applying deep learning across the biosciences
Sapoval, N., Aghazadeh, A., Nute, M. G., Antunes, D. A., Balaji, A., Baraniuk, R., Barberan, C. J., Dannenfelser, R., Dun, C., Edrisi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29268-7 · Cited by 359
“These methods are usually applied to well-curated, multi-omic datasets from large consortia (e.g., TCGA), and thus most often have been used to fi nd meaningful patient subgroups characterized by distinct patterns across data modalities.”
BackgroundThe impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Lindeboom, R. G. H., Vermeulen, M., Lehner, B., & Supek, F. (2019) · Nature Genetics · doi:10.1038/s41588-019-0517-5 · Cited by 327
Impact of a deep learning assistant on the histopathologic classification of liver cancer
Kiani, A., Uyumazturk, B., Rajpurkar, P., Wang, A., Gao, R., Jones, E., Yu, Y., Langlotz, C. P., Ball, R. L., Montine, T. J., et al. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-0232-8 · Cited by 325
“24 The WSI were randomly partitioned into training (20,000 patches from 20 WSI), tuning (2400 patches from 24 WSI) and validation (2600 patches from 26 WSI) datasets, maintaining a 50:50 distribution of HCC and CC examples within each dataset.”
MethodIntron retention is a source of neoepitopes in cancer
Smart, A. C., Margolis, C. A., Pimentel, H., He, M. X., Miao, D., Adeegbe, D., Fugmann, T., Wong, K.-K., & Van Allen, E. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4239 · Cited by 322
The metabolic landscape of RAS-driven cancers from biology to therapy
Mukhopadhyay, S., Vander Heiden, M. G., & McCormick, F. (2021) · Nature Cancer · doi:10.1038/s43018-021-00184-x · Cited by 315
Hickey, J. W., Neumann, E. K., Radtke, A. J., Camarillo, J. M., Beuschel, R. T., Albanese, A., McDonough, E., Hatler, J., Wiblin, A. E., Fisher, J., et al. (2022) · Nature Methods · doi:10.1038/s41592-021-01316-y · Cited by 311
Parikh, A. R., Szabolcs, A., Allen, J. N., Clark, J. W., Wo, J. Y., Raabe, M., Thel, H., Hoyos, D., Mehta, A., Arshad, S., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00269-7 · Cited by 294
“Common mutations in KRAS known to be pathogenic were then manually curated (chromosome 12, bases 25378562, 25380275, 25398281, 25398282, 25398284, and 25398285) corresponding to the top ten coding mutations in KRAS denoted in the Genomic Data Commons Database 57 if the sample already did not already contain a KRAS mut…”
Cancer transcriptome profiling at the juncture of clinical translation
Cieślik, M., & Chinnaiyan, A. M. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.96 · Cited by 269
Long-term cancer survival prediction using multimodal deep learning
Vale-Silva, L. A., & Rohr, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-92799-4 · Cited by 268
Convolutional neural network models for cancer type prediction based on gene expression
Mostavi, M., Chiu, Y.-C., Huang, Y., & Chen, Y. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-0677-2 · Cited by 264
“One prominent resource of cancer transcriptomic profiling is The Cancer Genome Atlas (TCGA) which consists of more than 11,000 tumors from 33 most frequent cancer types[7].”
BackgroundKörber, V., Yang, J., Barah, P., Wu, Y., Stichel, D., Gu, Z., Fletcher, M. N. C., Jones, D., Hentschel, B., Lamszus, K., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.007 · Cited by 260
Teixeira, V. H., Pipinikas, C. P., Pennycuick, A., Lee-Six, H., Chandrasekharan, D., Beane, J., Morris, T. J., Karpathakis, A., Feber, A., Breeze, C. E., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0323-0 · Cited by 259
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells
Cañellas-Socias, A., Cortina, C., Hernando-Momblona, X., Palomo-Ponce, S., Mulholland, E. J., Turon, G., Mateo, L., Conti, S., Roman, O., Sevillano, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05402-9 · Cited by 256
Weakly-supervised learning for lung carcinoma classification using deep learning
Kanavati, F., Toyokawa, G., Momosaki, S., Rambeau, M., Kozuma, Y., Shoji, F., Yamazaki, K., Takeo, S., Iizuka, O., & Tsuneki, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-66333-x · Cited by 250
Lizard: A Large-Scale Dataset for Colonic Nuclear Instance Segmentation and Classification
Graham, S., Jahanifar, M., Azam, A. S., Nimir, M., Tsang, Y., Dodd, K., Hero, E., Sahota, H., Tank, A., Benes, K., et al. (2021) · IEEE International Conference on Computer Vision Workshops · doi:10.1109/iccvw54120.2021.00082 · Cited by 246
“Similarly, MoNuSAC [37] provides the segmentation mask and class labels for nuclei extracted from TCGA and also sub-categorises inflammatory cells as either lymphocyte, neutrophil, eosinophil or macrophage.”
MethodInfluentialRole of machine learning in medical research: A survey
Garg, A., & Mago, V. (2021) · Computer Science Review · doi:10.1016/j.cosrev.2021.100370 · Cited by 243
Cancer epigenetics in clinical practice
Davalos, V., & Esteller, M. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21765 · Cited by 237
Deep learning for drug response prediction in cancer
Baptista, D., Ferreira, P. G., & Rocha, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 237
Cancer proteogenomics: current impact and future prospects
Mani, D. R., Krug, K., Zhang, B., Satpathy, S., Clauser, K. R., Ding, L., Ellis, M., Gillette, M. A., & Carr, S. A. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00446-5 · Cited by 229
Mutational signatures are jointly shaped by DNA damage and repair
Volkova, N. V., Meier, B., González-Huici, V., Bertolini, S., Gonzalez, S., Vöhringer, H., Abascal, F., Martincorena, I., Campbell, P. J., Gartner, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15912-7 · Cited by 228
Comprehensive characterization of protein–protein interactions perturbed by disease mutations
Cheng, F., Zhao, J., Wang, Y., Lu, W., Liu, Z., Zhou, Y., Martin, W. R., Wang, R., Huang, J., Hao, T., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00774-y · Cited by 227
NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling
Chowdhry, S., Zanca, C., Rajkumar, U., Koga, T., Diao, Y., Raviram, R., Liu, F., Turner, K., Yang, H., Brunk, E., et al. (2019) · Nature · doi:10.1038/s41586-019-1150-2 · Cited by 222
UCSCXenaShiny: an R/CRAN package for interactive analysis of UCSC Xena data
Wang, S., Xiong, Y., Zhao, L., Gu, K., Li, Y., Zhao, F., Li, J., Wang, M., Wang, H., Tao, Z., et al. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab561 · Cited by 198
A single-cell analysis of breast cancer cell lines to study tumour heterogeneity and drug response
Gambardella, G., Viscido, G., Tumaini, B., Isacchi, A., Bosotti, R., & di Bernardo, D. (2022) · Nature Communications · doi:10.1038/s41467-022-29358-6 · Cited by 195
Malireddi, R. K. S., Karki, R., Sundaram, B., Kancharana, B., Lee, S., Samir, P., & Kanneganti, T.-D. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2100059 · Cited by 194
“Normal expression data were downloaded from Genomic Data Commons Data Portal of National Cancer Institute (59).”
MethodUCSC Genome Browser enters 20th year
Lee, C. M., Barber, G. P., Casper, J., Clawson, H., Diekhans, M., Gonzalez, J. N., Hinrichs, A. S., Lee, B. T., Nassar, L. R., Powell, C. C., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1012 · Cited by 191
“Variant calls were downloaded from the Genomic Data Commons TCGA portal (14) and transformed into one track per cancer type as well as one merged track.”
MethodThe next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment
Rodriguez, H., Zenklusen, J. C., Staudt, L. M., Doroshow, J. H., & Lowy, D. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.055 · Cited by 189
Self-citationUniform genomic data analysis in the NCI Genomic Data Commons
Zhang, Z., Hernandez, K. M., Savage, J. H., Li, S., Miller, D. P., Agrawal, S., Ortuño, F. M., Staudt, L. M., Heath, A. P., & Grossman, R. L. (2021) · Nature Communications · doi:10.1038/s41467-021-21254-9 · Cited by 189
Self-citationGene expression based inference of cancer drug sensitivity
Chawla, S., Rockstroh, A., Lehman, M., Ratther, E., Jain, A., Anand, A., Gupta, A., Bhattacharya, N., Poonia, S., Rai, P., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33291-z · Cited by 183
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma
González, I. A., Stewart, D. R., Schultz, K. A. P., Field, A. P., Hill, D. A., & Dehner, L. P. (2022) · Modern Pathology · doi:10.1038/s41379-021-00905-8 · Cited by 182
Comprehensive Characterization of Alternative Polyadenylation in Human Cancer
Xiang, Y., Ye, Y., Lou, Y., Yang, Y., Cai, C., Zhang, Z., Mills, T., Chen, N.-Y., Kim, Y., Muge Ozguc, F., et al. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx223 · Cited by 180
Kieu, S. T. H., Bade, A., Hijazi, M. H. A., & Kolivand, H. (2020) · Journal of Imaging · doi:10.3390/jimaging6120131 · Cited by 179
An introduction and overview of machine learning in neurosurgical care
Senders, J. T., Zaki, M. M., Karhade, A. V., Chang, B., Gormley, W. B., Broekman, M. L., Smith, T. R., & Arnaout, O. (2018) · Acta Neurochirurgica · doi:10.1007/s00701-017-3385-8 · Cited by 178
Accurate diagnosis of colorectal cancer based on histopathology images using artificial intelligence
Wang, K. S., Yu, G., Xu, C., Meng, X. H., Zhou, J., Zheng, C., Deng, Z., Shang, L., Liu, R., Su, S., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01942-5 · Cited by 176
A Morphology Focused Diffusion Probabilistic Model for Synthesis of Histopathology Images
Moghadam, P. A., Dalen, S. V., Martin, K. C., Lennerz, J. K., Yip, S. S. F., Farahani, H., & Bashashati, A. (2023) · IEEE Winter Conference on Applications of Computer Vision · doi:10.1109/wacv56688.2023.00204 · Cited by 176
Computational pathology: A survey review and the way forward
Hosseini, M. S., Bejnordi, B. E., Trinh, V. Q., Chan, L., Hasan, D., Li, X., Yang, S. C., Kim, T., Zhang, H., Wu, T., et al. (2024) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2023.100357 · Cited by 176
NPInter v4.0: an integrated database of ncRNA interactions
Teng, X., Chen, X., Xue, H., Tang, Y., Zhang, P., Kang, Q., Hao, Y., Chen, R., Zhao, Y., & He, S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz969 · Cited by 171
“We also processed GDC TCGA cancer expression profiles (50).”
MethodChanging Trends in Computational Drug Repositioning
Yella, J. K., Yaddanapudi, S., Wang, Y., & Jegga, A. G. (2018) · Pharmaceuticals · doi:10.3390/ph11020057 · Cited by 166
Harmancı, A. S., Harmanci, A. O., & Zhou, X. (2020) · Nature Communications · doi:10.1038/s41467-019-13779-x · Cited by 166
“The corresponding bam fi les were downloaded from GDC data portal 43 .”
MethodAldo-Keto Reductases and Cancer Drug Resistance
Penning, T. M., Jonnalagadda, S. K., Trippier, P. C., & Rižner, T. L. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000122 · Cited by 166
“3) (Canning et al., 2015; Grossman et al., 2016).”
Multimodal data integration for oncology in the era of deep neural networks: a review
Waqas, A., Tripathi, A., Ramachandran, R. P., Stewart, P. A., & Rasool, G. (2024) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2024.1408843 · Cited by 165
Correlation Patterns Between DNA Methylation and Gene Expression in The Cancer Genome Atlas
Spainhour, J. C., Lim, H. S., Yi, S. V., & Qiu, P. (2019) · Cancer Informatics · doi:10.1177/1176935119828776 · Cited by 165
Crawford, L. A., Monod, A., Chen, A. X., Mukherjee, S., & Rabadán, R. (2019) · Journal of the American Statistical Association · doi:10.1080/01621459.2019.1671198 · Cited by 165
“recorded DFS and OS) that are publicly available [45,46].”
BackgroundCorrie, B. D., Marthandan, N., Zimonja, B., Jaglale, J., Zhou, Y., Barr, E., Knoetze, N., Breden, F. M. W., Christley, S., Scott, J. K., et al. (2018) · Immunological Reviews · doi:10.1111/imr.12666 · Cited by 164
“33 These structural models are as follows: • Fully centralized, where all data are integrated into a single repository (eg, The Cancer Data Commons 34 ) • Intermediate distributed, where repositories are distributed and separately maintained but are connected by a central resource and/or share…”
BackgroundBreast cancer: The translation of big genomic data to cancer precision medicine
Low, S., Zembutsu, H., & Nakamura, Y. (2017) · Cancer Science · doi:10.1111/cas.13463 · Cited by 160
Why All the Fuss about Oxidative Phosphorylation (OXPHOS)?
Xu, Y., Xue, D., Bankhead, A., & Neamati, N. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01013 · Cited by 159
Tong, L., Mitchel, J., Chatlin, K., & Wang, M. D. (2020) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-020-01225-8 · Cited by 158
Magnuson, A. M., Kiner, E., Ergün, A., Park, J. S., Asinovski, N., Ortiz-Lopez, A., Kilcoyne, A., Paoluzzi-Tomada, E., Weissleder, R., Mathis, D. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810580115 · Cited by 158
Klümper, N., Tran, N. K., Zschäbitz, S., Hahn, O., Büttner, T., Roghmann, F., Bolenz, C., Zengerling, F., Schwab, C., Nagy, D., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.01983 · Cited by 158
Berginski, M. E., Moret, N., Liu, C., Goldfarb, D., Sorger, P. K., & Gomez, S. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa853 · Cited by 156
“Data concerning cancer mutation, mRNA levels and copy number variations were downloaded from the TCGA firebrowse website using the FirebrowseR package (17).”
MethodSilva, T. C., Coetzee, S. G., Gull, N., Yao, L., Hazelett, D. J., Noushmehr, H., Lin, D., & Berman, B. P. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty902 · Cited by 155
Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome
Hollis, R. L., Thomson, J. P., Stanley, B., Churchman, M., Meynert, A. M., Rye, T., Bartos, C., Iida, Y., Croy, I., Mackean, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18819-5 · Cited by 154
Nongenetic Evolution Drives Lung Adenocarcinoma Spatial Heterogeneity and Progression
Tavernari, D., Battistello, E., Dheilly, E., Petruzzella, A. S., Mina, M., Sordet‐Dessimoz, J., Peters, S., Krueger, T., Gfeller, D., Riggi, N., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1274 · Cited by 153
Deep convolutional neural networks for accurate somatic mutation detection
Sahraeian, S. M. E., Liu, R., Lau, B., Podesta, K., Mohiyuddin, M., & Lam, H. Y. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09027-x · Cited by 150
Ostrowski, S. M., & Fisher, D. E. (2020) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2020.08.010 · Cited by 148
Bioinformatics in translational drug discovery
Wooller, S. K., Benstead-Hume, G., Chen, X., Ali, Y., & Pearl, F. M. G. (2017) · Bioscience Reports · doi:10.1042/bsr20160180 · Cited by 146
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
Hong, S. P., Chan, T. E., Lombardo, Y., Corleone, G., Rotmensz, N., Bravaccini, S., Rocca, A., Pruneri, G., McEwen, K. R., Coombes, R. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11721-9 · Cited by 145
Synthesis of diagnostic quality cancer pathology images by generative adversarial networks
Levine, A., Peng, J., Farnell, D., Nursey, M., Wang, Y., Naso, J. R., Ren, H., Farahani, H., Chen, C., Chiu, D. S., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5509 · Cited by 145
“In order to represent a wide range of distinctive morphologic characteristics, 668 WSIs corresponding to five cancer histotypes were taken from TCGA archive [24] with the following breakdown: LGG (333 slides), HCC (78 slides), LSCC (72 slides), RCC (104 slides), and PTC (81 slides).”
BackgroundThe Ubiquitin Ligase TRIP12 Limits PARP1 Trapping and Constrains PARP Inhibitor Efficiency
Gatti, M., Imhof, R., Huang, Q. D., Baudis, M., & Altmeyer, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107985 · Cited by 145
“Transcrip-tomics data were generated by the TCGA Research Network: https://www.cancer.gov/tcga (Grossman et al., 2016).”
MethodEnhancing transcription–replication conflict targets ecDNA-positive cancers
Tang, J., Weiser, N. E., Wang, G., Chowdhry, S., Curtis, E. J., Zhao, Y., Wong, I. T.-L., Marinov, G. K., Li, R., Hanoian, P., et al. (2024) · Nature · doi:10.1038/s41586-024-07802-5 · Cited by 144
Jaber, M. I., Song, B., Taylor, C. R., Vaske, C. J., Benz, S. C., Rabizadeh, S., Soon‐Shiong, P., & Szeto, C. W. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-1248-3 · Cited by 143
“All diagnostic WSIs of H&E-stained sections from formalin-fixed paraffin-embedded (FFPE) blocks collected from 1097 patients with invasive BC were obtained from The Cancer Genome Atlas (TCGA) data sources [25], resulting in a collection of 1142 diagnostic WSIs.”
MethodOmiEmbed: A Unified Multi-Task Deep Learning Framework for Multi-Omics Data
Zhang, X., Xing, Y., Sun, K., & Guo, Y. (2021) · Cancers · doi:10.3390/cancers13123047 · Cited by 141
“The model was trained and evaluated on two publicly available omics datasets, the Genomic Data Commons (GDC) pan-cancer multi-omics dataset [Grossman et al., 2016] and the GSE109381 brain tumour methylation (BTM) dataset [Capper et al., 2018].”
MethodMeisenberg, C., Pinder, S. I., Hopkins, S. R., Wooller, S. K., Benstead-Hume, G., Pearl, F. M. G., Jeggo, P. A., & Downs, J. A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.001 · Cited by 140
“…genome NCBI build 37, GRCh37 Genome Reference Consortium https://www.ncbi.nlm.nih.gov/ projects/genome/assembly/ grc/human/ Genomic data commons Grossman, 2016 N/A COSMIC database Forbes et al., 2017 https://cancer.sanger.ac.uk Raw data files deposited in Mendeley Data This paper…”
BackgroundTeng, K., Mansour, A. G., Zhu, Z. G., Li, Z., Tian, L., Ma, S., Xu, B., Lu, T., Chen, H., Hou, D., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.281 · Cited by 140
Wilson, M. R., Reske, J. J., Holladay, J., Moldovan, G. E., Rhodes, M., Koeman, J. M., Adams, M., Johnson, B. K., Su, R., Joshi, N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11403-6 · Cited by 138
Imperial, R. J. L., Ahmed, Z., Toor, O. M., Erdoğan, C., Khaliq, A. M., Case, P., Case, J., Kennedy, K. F., Cummings, L. S., Melton, N. M., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0923-9 · Cited by 136
“Additional file 1: Patients demographics from TCGA.”
MethodInfluentialDIANA-miTED: a microRNA tissue expression database
Kavakiotis, I., Alexiou, A. T., Tastsoglou, S., Vlachos, I. S., & Hatzigeorgiou, A. G. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab733 · Cited by 136
“TCGA sRNA-Seq datasets were retrieved using the GDC Data Transfer Tool, along with the respective transcriptomic metadata from the GDC data portal (24), while all available sample and patient metadata were retrieved.”
MethodASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth
Ma, W. K., Voss, D. M., Scharner, J., Costa, A. S. H., Lin, K., Jeon, H. Y., Wilkinson, J. E., Jackson, M., Rigo, F., Bennett, C. F., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0948 · Cited by 136
Effect Sizes of Somatic Mutations in Cancer
Cannataro, V. L., Gaffney, S. G., & Townsend, J. P. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy168 · Cited by 134
“served substitutions to the rate that substitutions would be expected to arise in the absence of selection (38) in data that either were obtained from TCGA projects downloaded from the National Cancer Institute’s Genomic Data Commons (28)”
MethodComputational analysis of cancer genome sequencing data
Cortés‐Ciriano, I., Gulhan, D., Lee, J. J.-K., Melloni, G. E. M., & Park, P. J. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00431-y · Cited by 133
A Practical Tutorial on Explainable AI Techniques
Bennetot, A., Donadello, I., El-Qadi, A., Dragoni, M., Frossard, T., Wagner, B., Saranti, A., Tulli, S., Trocan, M., Chatila, R., et al. (2024) · ACM Computing Surveys · doi:10.1145/3670685 · Cited by 131
“…Layer-wise Relevance Propagation (LRP) [61] Graph Visual Image Classification TCGA and Target[37] Original LRP for Graphs Repository: https://git.tu-berlin.de/thomas_schnake/demo_gnn_lrp LRP for Graphs practical case guide:…”
Dreßler, L., Bortolomeazzi, M., Keddar, M. R., Mišetić, H., Sartini, G., Acha‐Sagredo, A., Montorsi, L., Wijewardhane, N., Repana, D., Nulsen, J., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02607-z · Cited by 129
“Original data were obtained from the following online sources: 1000 Genomes Project Phase 3 [103] v.5a: https://www.internationalgenome.org/category/phase-3/ BioGRID [93] v.3.5.185: https://thebiogrid.org/ Bioplex [97] v.3.0: https://bioplex.hms.harvard.edu/interactions.php CORUM [98] v.3.0: http://mips.helmholtz-muen…”
BackgroundMethodInfluential
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.